Basel Medical (BMGL) Income towards Parent Company (2024 - 2025)

Basel Medical (BMGL) posted Income towards Parent Company of $160458.0 for Q4 2025, up 150.61% sequentially from -$317031.0 in Q4 2024, and up 150.61% YoY from $64026.3 in Q4 2024.

Basel Medical (BMGL) Income towards Parent Company (2024 - 2025) Analysis & Trends

Basel Medical (BMGL) has 2 years of Income towards Parent Company data on file, last reported at $160458.0 in Q4 2025.

  • Quarterly Income towards Parent Company rose 150.61% year-over-year to $160458.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$156573.0 (changed N/A YoY) and the FY2025 annual result came in at -$8.4 million, down 645.8% from the prior year.
  • Income towards Parent Company rose to $160458.0 in Q4 2025 per BMGL's latest filing, from -$317031.0 in the prior quarter.
  • The five-year high for Income towards Parent Company was $160458.0 in Q4 2025, with the low at -$317031.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 87.94 Bn 90.32 Bn 16.26 Bn
2 Chemed 18.08 Bn 18.07 Bn 215.76 Mn
3 Tenet Healthcare 16.59 Bn 15.76 Bn 4.41 Bn
4 Davita 15.37 Bn 16.23 Bn 1.07 Bn
5 Encompass Health 10.07 Bn 10.70 Bn 1.34 Bn
6 Ensign 9.52 Bn 8.93 Bn 293.37 Mn
7 Universal Health Services 9.19 Bn 9.15 Bn 3.21 Bn
8 Pacs 6.96 Bn 6.72 Bn 345.96 Mn
9 Ww International 6.14 Bn 5.98 Bn -149.29 Mn
10 Basel Medical 133.19 Mn 130.39 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 160,458.00
Dec 31, 2024 -317,031.00